Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 4/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.34 |
| ▸ | HPGD | P15428 | 2/20 | 0.34 |
| ▸ | MAPT | P10636 | 1/20 | 0.34 |
| ▸ | THRB | P10828 | 1/20 | 0.34 |
| ▸ | RECQL | P46063 | 1/20 | 0.34 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.34 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.34 |
| ▸ | HTT | P42858 | 1/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
| ▸ | PKM | P14618 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22382787 | 0.98 | KMT2A (0.34) | KMT2AALDH1A1HPGDMAPTTHRB | |
| SCHEMBL22382921 | 0.95 | KMT2A (0.32) | KMT2AALDH1A1HPGDMAPTTHRB | |
| SCHEMBL22382788 | 0.92 | KMT2A (0.34) | KMT2AALDH1A1HPGDMAPTTHRB | |
| SCHEMBL22382913 | 0.89 | — | — | |
| SCHEMBL22382919 | 0.87 | KMT2A (0.32) | KMT2AALDH1A1HPGDMAPTTHRB | |
| SCHEMBL23862409 | 0.86 | KMT2A (0.39) | KMT2AALDH1A1HPGDMAPTTHRB | |
| SCHEMBL20040160 | 0.85 | KMT2A (0.33) | KMT2AALDH1A1HPGDMAPTTHRB | |
| SCHEMBL22382781 | 0.85 | ALDH1A1 (0.31) | KMT2AALDH1A1HPGDMAPTTHRB | |
| SCHEMBL23515596 | 0.85 | KMT2A (0.37) | KMT2AALDH1A1HPGDMAPTTHRB | |
| SCHEMBL23515584 | 0.84 | ALDH1A1 (0.40) | KMT2AALDH1A1HPGDMAPTTHRB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3481834-B1 | ORGANIC SEMICONDUCTING COMPOUNDS | RAYNERGY TEK INC (TW) | 2023-10-18 | — | — | EP | disclosed |
| EP-3500577-B1 | ORGANIC SEMICONDUCTING COMPOUNDS | RAYNERGY TEK INC (TW) | 2021-12-01 | — | — | EP | disclosed |
| US-10759775-B2 | Organic semiconducting compounds | MERCK PATENT GMBH (DE) | 2020-09-01 | — | — | US | disclosed |
| US-20190214581-A1 | ORGANIC SEMICONDUCTING COMPOUNDS | MERCK PATENT GMBH (DE) | 2019-07-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190214581-A1 | ORGANIC SEMICONDUCTING COMPOUNDS | OCIAD2, OCIAD1, EED | KMT2A 721/4885ALDH1A1 2581/4885HPGD 1628/4885 |
| US-10759775-B2 | Organic semiconducting compounds | OCIAD2, OCIAD1, OSTC | KMT2A 1050/4885ALDH1A1 3327/4885HPGD 1363/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.